<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39386210</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Exploring the role of galectin-9 and artemin as biomarkers in long COVID with chronic fatigue syndrome: links to inflammation and cognitive function.</ArticleTitle><Pagination><StartPage>1443363</StartPage><MedlinePgn>1443363</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1443363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1443363</ELocationID><Abstract><AbstractText>This study aimed to assess plasma galectin-9 (Gal-9) and artemin (ARTN) concentrations as potential biomarkers to differentiate individuals with Long COVID (LC) patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) from SARS-CoV-2 recovered (R) and healthy controls (HCs). Receiver operating characteristic (ROC) curve analysis determined a cut-off value of plasma Gal-9 and ARTN to differentiate LC patients from the R group and HCs in two independent cohorts. Positive correlations were observed between elevated plasma Gal-9 levels and inflammatory markers (e.g. SAA and IP-10), as well as sCD14 and I-FABP in LC patients. Gal-9 also exhibited a positive correlation with cognitive failure scores, suggesting its potential role in cognitive impairment in LC patients with ME/CFS. This study highlights plasma Gal-9 and/or ARTN as sensitive screening biomarkers for discriminating LC patients from controls. Notably, the elevation of LPS-binding protein in LC patients, as has been observed in HIV infected individuals, suggests microbial translocation. However, despite elevated Gal-9, we found a significant decline in ARTN levels in the plasma of people living with HIV (PLWH). Our study provides a novel and important role for Gal-9/ARTN in LC pathogenesis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elahi, Rezaeifar, Osman and Shahbaz.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elahi</LastName><ForeName>Shokrollah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Virology, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Women and Children Health Research Institute, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Research Institute of Northern Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Glycomics Institute of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alberta Transplant Institute, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaeifar</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Li Ka Shing Institute of Virology, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Women and Children Health Research Institute, Edmonton, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Rheumatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahbaz</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Dentistry, Division of Foundational Sciences, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037161">Galectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105032">LGALS9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C081856">LGALS3BP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000951">Antigens, Neoplasm</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037161" MajorTopicYN="Y">Galectins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="Y">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000951" MajorTopicYN="N">Antigens, Neoplasm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">artemin</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">galectin-9</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">microbial translocation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39386210</ArticleId><ArticleId IdType="pmc">PMC11461188</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1443363</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. (2022) 70:61&#x2013;7. doi:&#xa0;10.1136/jim-2021-002051</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, O'Hara M, Evans S, Agyen L, et al. . Long COVID guidelines need to reflect lived experience. Lancet. (2021) 397:455&#x2013;7. doi:&#xa0;10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Shahbaz S, Luo X, Osman M, Redmond D, Cohen Tervaert JW, et al. . Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front Immunol. (2024) 15:1341843. doi:&#xa0;10.3389/fimmu.2024.1341843</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341843</ArticleId><ArticleId IdType="pmc">PMC10830702</ArticleId><ArticleId IdType="pubmed">38304426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9&#x2013;611.e16. doi:&#xa0;10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). (2005) 55:20&#x2013;31. doi:&#xa0;10.1093/occmed/kqi013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. . Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Trans Med. (2022) 20:138. doi:&#xa0;10.1186/s12967-022-03346-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu PW, Gehlhausen JR, et al. . Distinguishing features of long COVID identified through immune profiling. Nature. (2023) 623:139&#x2013;48. doi:&#xa0;10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota HR, Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol. (2022) 41:337&#x2013;48. doi:&#xa0;10.1007/s10067-021-06001-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Front Pharmacol. (2022) 13:899198. doi:&#xa0;10.3389/fphar.2022.899198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, et al. . Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. (2024) 25:218&#x2013;25. doi:&#xa0;10.1038/s41590-023-01724-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo W, He D, Liang C, Du S, Hua Z, Nie Q, et al. . The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect Dis. (2024) 24(8):845&#x2013;55. doi:&#xa0;10.1016/S1473-3099(24)00171-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00171-3</ArticleId><ArticleId IdType="pubmed">38663423</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). (2021) 21:e63&#x2013;e7. doi:&#xa0;10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, Zaporojan L, et al. . Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. (2024) 27:421&#x2013;32. doi:&#xa0;10.1038/s41593-024-01576-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Mothes R, Heppner FL, Radbruch H. What SARS-CoV-2 does to our brains. Immunity. (2022) 55:1159&#x2013;72. doi:&#xa0;10.1016/j.immuni.2022.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9212726</ArticleId><ArticleId IdType="pubmed">35777361</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan N, Whiteside M, Herkenham M. Time course and localization patterns of interleukin-1beta messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. (1998) 83:281&#x2013;93. doi:&#xa0;10.1016/s0306-4522(97)00350-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0306-4522(97)00350-3</ArticleId><ArticleId IdType="pubmed">9466417</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL, Johnson RW. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci. (2006) 26:10709&#x2013;16. doi:&#xa0;10.1523/JNEUROSCI.3376-06.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3376-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674759</ArticleId><ArticleId IdType="pubmed">17050710</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dam AM, Brouns M, Louisse S, Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. (1992) 588:291&#x2013;6. doi:&#xa0;10.1016/0006-8993(92)91588-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(92)91588-6</ArticleId><ArticleId IdType="pubmed">1393581</ArticleId></ArticleIdList></Reference><Reference><Citation>Merani S, Chen W, Elahi S. The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections. Rev Med virology. (2015) 25:175&#x2013;86. doi:&#xa0;10.1002/rmv.1832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1832</ArticleId><ArticleId IdType="pubmed">25760439</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunsmore G, Rosero EP, Shahbaz S, Santer DM, Jovel J, Lacy P, et al. . Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection. PloS Biol. (2021) 19:e3001387. doi:&#xa0;10.1371/journal.pbio.3001387</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001387</ArticleId><ArticleId IdType="pmc">PMC8407585</ArticleId><ArticleId IdType="pubmed">34411088</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S, Niki T, Hirashima M, Horton H. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood. (2012) 119:4192&#x2013;204. doi:&#xa0;10.1182/blood-2011-11-389585</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-389585</ArticleId><ArticleId IdType="pmc">PMC3359739</ArticleId><ArticleId IdType="pubmed">22438246</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoye I, Xu L, Motamedi M, Parashar P, Walker JW, Elahi S. Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors. J Immunotherapy Cancer. (2020) 8:e001849. doi:&#xa0;10.1136/jitc-2020-001849</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-001849</ArticleId><ArticleId IdType="pmc">PMC7735134</ArticleId><ArticleId IdType="pubmed">33310773</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati ABS, Elahi S. Galectin-9 promotes natural killer cells activity via interaction with CD44. Front Immunol. (2023) 14:1131379. doi:&#xa0;10.3389/fimmu.2023.1131379</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1131379</ArticleId><ArticleId IdType="pmc">PMC10060867</ArticleId><ArticleId IdType="pubmed">37006235</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Dunsmore G, Koleva P, Xu L, Houston S, Elahi S. Galectin-9 and VISTA expression define terminally exhausted T cells in HIV-1 infection. J Immunol. (2020) 204:2474&#x2013;91. doi:&#xa0;10.4049/jimmunol.1901481</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1901481</ArticleId><ArticleId IdType="pubmed">32205423</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Hnatiuk M, Peters AC, Elahi S. Depletion of polyfunctional CD26(high)CD8(+) T cells repertoire in chronic lymphocytic leukemia. Exp Hematol Oncol. (2023) 12:13. doi:&#xa0;10.1186/s40164-023-00375-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40164-023-00375-5</ArticleId><ArticleId IdType="pmc">PMC9881277</ArticleId><ArticleId IdType="pubmed">36707896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K, Elahi S, Mashhouri S, Ye C. Gout presenting as a chronic inflammatory arthritis from immune checkpoint inhibitors: case series. Rheumatology. (2021) 60:E441&#x2013;E3. doi:&#xa0;10.1093/rheumatology/keab608</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab608</ArticleId><ArticleId IdType="pubmed">34320630</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Rosero E, Heron S, Jovel J, O'Neil CR, Turvey SL, Parashar P, et al. . Differential signature of the microbiome and neutrophils in the oral cavity of HIV-infected individuals. Front Immunol. (2021) 12:780910. doi:&#xa0;10.3389/fimmu.2021.780910</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.780910</ArticleId><ArticleId IdType="pmc">PMC8630784</ArticleId><ArticleId IdType="pubmed">34858437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Mashhouri S, Perez Rosero E, Xu L, Shahbaz S, Sligl W, et al. . Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-CoV-2 infection. mBio. (2021) 12:e00384&#x2013;21. doi:&#xa0;10.1128/mBio.00384-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00384-21</ArticleId><ArticleId IdType="pmc">PMC8262904</ArticleId><ArticleId IdType="pubmed">33947753</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Shahbaz S, Osman M, Redmond D, Bozorgmehr N, Rosychuk RJ, et al. . Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome. J Autoimmun. (2024) 147:103267. doi:&#xa0;10.1016/j.jaut.2024.103267</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2024.103267</ArticleId><ArticleId IdType="pubmed">38797051</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogariu AM, Dumitrascu DL. Digestive involvement in the Long-COVID syndrome. Med Pharm Rep. (2022) 95:5&#x2013;10. doi:&#xa0;10.15386/mpr-2340</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-2340</ArticleId><ArticleId IdType="pmc">PMC9177081</ArticleId><ArticleId IdType="pubmed">35720240</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, et al. . Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. (2022) 163:495&#x2013;506.e8. doi:&#xa0;10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenchley JM. Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol. (2013) 6:657&#x2013;65. doi:&#xa0;10.1038/mi.2013.15</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2013.15</ArticleId><ArticleId IdType="pmc">PMC4154146</ArticleId><ArticleId IdType="pubmed">23549448</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh A, Epeldegui M, Karlamangla AS, Greendale GA. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight. (2020) 5:e134092. doi:&#xa0;10.1172/jci.insight.134092</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.134092</ArticleId><ArticleId IdType="pmc">PMC7098720</ArticleId><ArticleId IdType="pubmed">31830000</ArticleId></ArticleIdList></Reference><Reference><Citation>Premeaux TA, Yeung ST, Pillai SK, Ndhlovu LC. Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states. J Neurovirol. (2023) 29:337&#x2013;45. doi:&#xa0;10.1007/s13365-023-01149-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-023-01149-9</ArticleId><ArticleId IdType="pubmed">37233903</ArticleId></ArticleIdList></Reference><Reference><Citation>Minnema L, Wheeler J, Enomoto M, Pitake S, Mishra SK, Lascelles BDX. Correlation of artemin and GFRalpha3 with osteoarthritis pain: early evidence from naturally occurring osteoarthritis-associated chronic pain in dogs. Front Neurosci. (2020) 14:77. doi:&#xa0;10.3389/fnins.2020.00077</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00077</ArticleId><ArticleId IdType="pmc">PMC7031206</ArticleId><ArticleId IdType="pubmed">32116521</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardell LR, Wang R, Ehrenfels C, Ossipov MH, Rossomando AJ, Miller S, et al. . Multiple actions of systemic artemin in experimental neuropathy. Nat Med. (2003) 9:1383&#x2013;9. doi:&#xa0;10.1038/nm944</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm944</ArticleId><ArticleId IdType="pubmed">14528299</ArticleId></ArticleIdList></Reference><Reference><Citation>Moar P, Linn K, Premeaux TA, Bowler S, Sardarni UK, Gopalan BP, et al. . Plasma Galectin-9 relates to cognitive performance and inflammation among adolescents with vertically acquired HIV. Aids. (2024) 38:1460&#x2013;7. doi:&#xa0;10.1097/QAD.0000000000003907</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000003907</ArticleId><ArticleId IdType="pmc">PMC11239096</ArticleId><ArticleId IdType="pubmed">38608008</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S, Weiss RH, Merani S. Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21. Aids. (2016) 30:171&#x2013;83. doi:&#xa0;10.1097/QAD.0000000000000917</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000000917</ArticleId><ArticleId IdType="pubmed">26645604</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S. Galectin-9, a lingering shadow in HIV's fight: the unseen battle of adolescents with perinatally-acquired HIV. Aids. (2024) 38:1589&#x2013;91. doi:&#xa0;10.1097/QAD.0000000000003941</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000003941</ArticleId><ArticleId IdType="pubmed">38990316</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Sunnquist M, Brown A, Evans M, Vernon SD, Furst J, et al. . Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis. Fatigue. (2014) 2:40&#x2013;56. doi:&#xa0;10.1080/21641846.2013.862993</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2013.862993</ArticleId><ArticleId IdType="pmc">PMC3912876</ArticleId><ArticleId IdType="pubmed">24511456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Trans Med. (2020) 18:100. doi:&#xa0;10.1186/s12967-020-02269-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Okoye I, Blevins G, Elahi S. Elevated ATP via enhanced miRNA-30b, 30c, and 30e downregulates the expression of CD73 in CD8+ T cells of HIV-infected individuals. PloS Pathog. (2022) 18:e1010378. doi:&#xa0;10.1371/journal.ppat.1010378</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010378</ArticleId><ArticleId IdType="pmc">PMC8947394</ArticleId><ArticleId IdType="pubmed">35325005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Okoye I, Oyegbami O, Xu L, Fontaine A, Cox-Kennett N, et al. . Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia. J Immunother Cancer. (2021) 9(4):e002189. doi:&#xa0;10.1136/jitc-2020-002189</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-002189</ArticleId><ArticleId IdType="pmc">PMC8098955</ArticleId><ArticleId IdType="pubmed">33931471</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Bozorgmehr N, Lu J, Osman M, Sligl W, Tyrrell DL, et al. . Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles. Microbiol Spectr. (2023) 11:e0125623. doi:&#xa0;10.1128/spectrum.01256-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01256-23</ArticleId><ArticleId IdType="pmc">PMC10581158</ArticleId><ArticleId IdType="pubmed">37676005</ArticleId></ArticleIdList></Reference><Reference><Citation>Premeaux TA, D'Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK, et al. . Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. J Neurovirology. (2019) 25:150&#x2013;61. doi:&#xa0;10.1007/s13365-018-0696-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-018-0696-3</ArticleId><ArticleId IdType="pmc">PMC6506351</ArticleId><ArticleId IdType="pubmed">30478799</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh RH, Tansey MG, Lampe PA, Fahrner TJ, Enomoto H, Simburger KS, et al. . Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFR&#x3b1;3-RET receptor complex. Neuron. (1998) 21:1291&#x2013;302. doi:&#xa0;10.1016/s0896-6273(00)80649-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(00)80649-2</ArticleId><ArticleId IdType="pubmed">9883723</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh S, Ikeda M, Shimizu H, Fukushima K, Oka M. Induction of galectin-9 production by viral infection in the lung. Eur Respir J. (2015) 46:OA1780. doi:&#xa0;10.1183/13993003.congress-2015.OA1780</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.congress-2015.OA1780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, McWilliams R, et al. . A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PloS One. (2010) 5:e9504. doi:&#xa0;10.1371/journal.pone.0009504</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009504</ArticleId><ArticleId IdType="pmc">PMC2831996</ArticleId><ArticleId IdType="pubmed">20209097</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka N, Kozuru H, Koga T, Abiru S, Yamasaki K, Komori A, et al. . Galectin-9 in autoimmune hepatitis Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis. Medicine. (2019) 98:e16924. doi:&#xa0;10.1097/MD.0000000000016924</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016924</ArticleId><ArticleId IdType="pmc">PMC6736219</ArticleId><ArticleId IdType="pubmed">31464928</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S, Dinges WL, Lejarcegui N, Laing KJ, Collier AC, Koelle DM, et al. . Protective HIV-specific CD8+ T cells evade Treg cell suppression. Nat Med. (2011) 17:989&#x2013;95. doi:&#xa0;10.1038/nm.2422</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2422</ArticleId><ArticleId IdType="pmc">PMC3324980</ArticleId><ArticleId IdType="pubmed">21765403</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Sun L, Li C-F, Wang Y-H, Yao J, Li H, et al. . Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. (2021) 12:832. doi:&#xa0;10.1038/s41467-021-21099-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21099-2</ArticleId><ArticleId IdType="pmc">PMC7864927</ArticleId><ArticleId IdType="pubmed">33547304</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HY, Wu YF, Chou FC, Wu YH, Yeh LT, Lin KI, et al. . Intracellular galectin-9 enhances proximal TCR signaling and potentiates autoimmune diseases. J Immunol. (2020) 204:1158&#x2013;72. doi:&#xa0;10.4049/jimmunol.1901114</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1901114</ArticleId><ArticleId IdType="pubmed">31969388</ArticleId></ArticleIdList></Reference><Reference><Citation>Motamedi M, Shahbaz S, Fu L, Dunsmore G, Xu L, Harrington R, et al. . Galectin-9 expression defines a subpopulation of NK cells with impaired cytotoxic effector molecules but enhanced IFN-gamma production, dichotomous to TIGIT, in HIV-1 infection. Immunohorizons. (2019) 3:531&#x2013;46. doi:&#xa0;10.4049/immunohorizons.1900087</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.1900087</ArticleId><ArticleId IdType="pubmed">31732662</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin TR, Wurfel MM, Zanoni I, Ulevitch R. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness. Ebiomedicine. (2020) 57:102836. doi:&#xa0;10.1016/j.ebiom.2020.102836</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102836</ArticleId><ArticleId IdType="pmc">PMC7305752</ArticleId><ArticleId IdType="pubmed">32574958</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao VT, Carter MC, Brenchley JM, Bolan H, Scott LM, Bai Y, et al. . sCD14 and intestinal fatty acid binding protein are elevated in the serum of patients with idiopathic anaphylaxis. J Allergy Clin Immunol Pract. (2023) 11:2080&#x2013;6.e5. doi:&#xa0;10.1016/j.jaip.2023.03.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2023.03.037</ArticleId><ArticleId IdType="pmc">PMC10411508</ArticleId><ArticleId IdType="pubmed">36997122</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassallo M, Merci&#xe9; P, Cottalorda J, Ticchioni M, Dellamonica P. The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review. Virol J. (2012) 9:174. doi:&#xa0;10.1186/1743-422X-9-174</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-174</ArticleId><ArticleId IdType="pmc">PMC3495848</ArticleId><ArticleId IdType="pubmed">22925532</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. . Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. (2022) 3:371&#x2013;87.e9. doi:&#xa0;10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Icard P, Lincet H. A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Biochim Biophys Acta. (2012) 1826:423&#x2013;33. doi:&#xa0;10.1016/j.bbcan.2012.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2012.07.001</ArticleId><ArticleId IdType="pubmed">22841746</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Bozorgmehr N, Sligl W, Osman M, Elahi S. The role of coinhibitory receptors in B cell dysregulation in SARS-CoV-2-infected individuals with severe disease. J Immunol. (2024) 212:1540&#x2013;52. doi:&#xa0;10.4049/jimmunol.2300783</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2300783</ArticleId><ArticleId IdType="pmc">PMC11075007</ArticleId><ArticleId IdType="pubmed">38517295</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. . COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. (2020) 5:e140327. doi:&#xa0;10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Du L, Bouzidi MS, Gala A, Deiter F, Billaud JN, Yeung ST, et al. . Human galectin-9 potently enhances SARS-CoV-2 replication and inflammation in airway epithelial cells. J Mol Cell Biol. (2023) 15(4):mjad030. doi:&#xa0;10.1093/jmcb/mjad030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjad030</ArticleId><ArticleId IdType="pmc">PMC10668544</ArticleId><ArticleId IdType="pubmed">37127426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi SG, Hong PW, Lee B, Baum LG. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci United States America. (2011) 108:10650&#x2013;5. doi:&#xa0;10.1073/pnas.1017954108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017954108</ArticleId><ArticleId IdType="pmc">PMC3127870</ArticleId><ArticleId IdType="pubmed">21670307</ArticleId></ArticleIdList></Reference><Reference><Citation>Steelman AJ, Li J. Astrocyte galectin-9 potentiates microglial TNF secretion. J Neuroinflammation. (2014) 11:144. doi:&#xa0;10.1186/s12974-014-0144-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-014-0144-0</ArticleId><ArticleId IdType="pmc">PMC4158089</ArticleId><ArticleId IdType="pubmed">25158758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Li Y, Bennett S, Chen J, Weng IZ, Huang L, et al. . The role of glial cell line-derived neurotrophic factor family member artemin in neurological disorders and cancers. Cell Prolif. (2020) 53:e12860. doi:&#xa0;10.1111/cpr.12860</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cpr.12860</ArticleId><ArticleId IdType="pmc">PMC7377943</ArticleId><ArticleId IdType="pubmed">32573073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, et al. . Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol. (2022) 13:1070379. doi:&#xa0;10.3389/fimmu.2022.1070379</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070379</ArticleId><ArticleId IdType="pmc">PMC9798841</ArticleId><ArticleId IdType="pubmed">36591311</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahi S, Vega-Lopez MA, Herman-Miguel V, Ramirez-Estudillo C, Mancilla-Ramirez J, Motyka B, et al. . CD71(+) erythroid cells in human neonates exhibit immunosuppressive properties and compromise immune response against systemic infection in neonatal mice. Front Immunol. (2020) 11:597433. doi:&#xa0;10.3389/fimmu.2020.597433</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.597433</ArticleId><ArticleId IdType="pmc">PMC7732591</ArticleId><ArticleId IdType="pubmed">33329589</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Xu L, Osman M, Sligl W, Shields J, Joyce M, et al. . Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Rep. (2021) 16:1165&#x2013;81. doi:&#xa0;10.1016/j.stemcr.2021.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8111797</ArticleId><ArticleId IdType="pubmed">33979601</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozorgmehr N, Okoye I, Mashhouri S, Lu J, Koleva P, Walker J, et al. . CD71(+) erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors. J Immunother Cancer. (2023) 11:e006595. doi:&#xa0;10.1136/jitc-2022-006595</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2022-006595</ArticleId><ArticleId IdType="pmc">PMC10230995</ArticleId><ArticleId IdType="pubmed">37236637</ArticleId></ArticleIdList></Reference><Reference><Citation>Namdar A, Koleva P, Shahbaz S, Strom S, Gerdts V, Elahi S. CD71+ erythroid suppressor cells impair adaptive immunity against Bordetella pertussis. Sci Rep. (2017) 7:7728. doi:&#xa0;10.1038/s41598-017-07938-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07938-7</ArticleId><ArticleId IdType="pmc">PMC5552872</ArticleId><ArticleId IdType="pubmed">28798335</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes SM, Jamoulle M, Carletto MP, Moens L, Meyts I, Maes P, et al. . Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition. Lancet Microbe. (2024) 5(8):100849. doi:&#xa0;10.1016/S2666-5247(24)00055-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(24)00055-7</ArticleId><ArticleId IdType="pubmed">38677304</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbaz S, Sligl W, Osman M, Elahi S. Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV. Allergy Asthma Cl Im. (2023) 19(1):91. doi:&#xa0;10.1186/s13223-023-00846-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-023-00846-8</ArticleId><ArticleId IdType="pmc">PMC10583436</ArticleId><ArticleId IdType="pubmed">37848967</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>